Nytt hopp om att behandla blodcancer

Forskare vid Uppsala universitet har gjort en upptäckt om blodcancertypen multipelt myelom som ger hopp om nya behandlingsmetoder.

DKK 1,3 billion for grand research

Danish Councils for Independent Research, DFF, will grant DKK 1,3 billion during 2009. Now has the application period started.

Lund honours milieu enthusiast

Four professors at the University of Lund has appointed the milieu chief of the university as honorary doctor.

Bio-Linux goes global

Recently the NEBC Bio-Linux Version 5.0 was released, a one-stop shop for bioinformatics tools in a Linux context.

Printing sensors for biological samples

Acreo develops technologies for printed electronics. Using organic printers, Acreo can print a transistor where biological samples can be placed.

"An open mind is the key to successful meetings"

Meeting in person is irreplaceble when it comes to finding a new partner. Johan Ohlsson at Venture Valuation is happy with his meetings at Biotech Forum so far ...

Ny leveransteknik vinner mark

Uppsalabolaget Disruptive Materials blev världskända över en natt när publikationen om deras porösa nanomaterial Upsalite kom ut förra sommaren. Nu diskuterar b...

New NO product reduces diabetic pain

The Swedish medtech company Nolabs has announced that it has achieved an important milestone in the development of a new line of products.

EUR 2 million for peanut allergies

ALK Abelló has signed an agreement to invest EUR 2 million in the French biotechnology company DBV Technologies.

Woman deficit in Swedish research

The IP firm Awapatent will soon launch its Innovation Barometer 2009. This year Awapatent reveals that the statistics is even worse, compared to last year.

Blood type decide resistance to HIV

A Canadian-Swedish research team has found a blood type molecule that increases the resistance to HIV-infections.

Bring talent to those in need

Ho ho ho, Christmas time is here again. So get busy decking the halls, perhaps not with assorted greenery, but with something of a more lasting value.

Meda gets access to Asia

The biotech giant Meda has recently acquires world-wide rights to the cancer breakthrough pain drug Onsolis.

Floppat diabetesvaccin visar positiv effekt

Nya forskningsresultat visar att Diamyd-vaccinets immunologiska effekt håller i sig fyra år efter behandling.

Respiratorius hunts millions

The biopharmaceutical company Respiratorius has got a new CEO, who starts a public new share issue to catch almost SEK ten million.

LEO Pharma - International Clinical Trial Manager

Prenatal testing breakthrough

For the first time specific gene expression information from fetal cells isolated from maternal blood samples is available.

Diagnostics for personalized medicine

Per Matsson from Phadia anticipates changes in the standards for health care. Accordiing to him, expensive new drugs will create a market for more extensive diagnostics.

Focusing on Medicon Valley

Copenhagen Capacity and Invest in Skåne are hosting a seminar to promote the geographical area known as Medicon Valley. Some of the 350 life science companies f...

Mingling types - who to aim for and who to avoid:

Read about different mingling types - who are you?

EU says yes to Roche drug

EU approves a first in class therapy for treatment of patients with moderate to severe form of rheumatoid arthritis.

We are poor lobbyists

I doubt there has ever been a really well thought out Scandinavian campaign with intentions to really change attitudes among both the public and politicians.

Grape extract kills cancer cells

Grapes contain potentially beneficial chemicals that can destroy cancer cells, a new research proves.

EU tar krafttag för kliniska prövningar

Ska räcka att lämna in en ansökan om tillstånd till hela EU.